From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

Private equity ownership of psychiatric hospitals grew rapidly from 2013 to 2021, but the quality of care did not diminish ...

A recovery from this prolonged and painful market downturn will require a major attitude adjustment from biotech management ...

A “genetic surgery” or “interventional genetics” system for individualized treatments would be a marriage of drug development ...

CMS will hire nearly 2,000 coders to conduct audits to confirm diagnoses used for payment are backed by medical records.

The suit, filed Tuesday in the U.S. District Court for the District of Maryland, charges that cutting $800 million in medical ...

This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.

ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without ...

But the framework has perhaps created as much confusion as clarity. Broadly, the FDA said it will limit approval of Covid-19 ...

Latest draft of House tax cut bill calls for starting Medicaid work requirements next year, up from 2029, according to Rep.

Scientists see a worrying rise in late-stage prostate cancer diagnoses. Experts say prostate cancer screening, once seen as ...